Twelve weeks treatment with the DPP-4 inhibitor sitagliptin improves glycaemic control, but does not improve GLP-1 secretion, in patients with type 2 diabetes - a randomised trial

Research output: Contribution to journalConference abstract in journalResearch

K. Aaboe, F.K. Knop, Tina Vilsbøll, Carolyn F. Deacon, Jens Juul Holst, S. Madsbad, T. Krarup

Original languageEnglish
JournalDiabetologia
Pages (from-to)748
ISSN0012-186X
Publication statusPublished - 2009
EventTwelve weeks treatment with the DPP-4 inhibitor sitagliptin improves glycaemic control, but does not improve GLP-1 secretion, in patients with type 2 diabetes - a randomised trial -
Duration: 29 Nov 2010 → …

Conference

ConferenceTwelve weeks treatment with the DPP-4 inhibitor sitagliptin improves glycaemic control, but does not improve GLP-1 secretion, in patients with type 2 diabetes - a randomised trial
Period29/11/2010 → …

ID: 21544857